Volver al Panel








GeneDx Holdings Corp. (WGS)
Valores intradiarios en tiempo real
Resumen del Mercado
From:
To:
WGS Intraday
No data available
SímboloWGS
Fecha de SalidaNov 4, 2020
CEOMs. Katherine A. Stueland
Empleados a Tiempo Completo1.3k
SectorHealthcare
IndustriaDiagnostics & Research
PaísUnited States
BolsaNasdaqGS
GeneDx Holdings Corp., a genomics company, provides genetic testing services. The company primarily offers pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing, as well as data and information services. It also develops an AI-based platform for next generation sequencing analysis, interpretation, and clinical reporting for rare disease, hereditary risk, and cancer testing. GeneDx Holdings Corp. was founded in 2000 and is headquartered in Stamford, Connecticut.
Rendimiento
| Período | Rentabilidad % | Cambio de Valor |
|---|---|---|
| 1 Día | -14.26% | -12.61 US$ |
| 5 Días | -11.04% | -9.41 US$ |
| 1 Mes | -12.21% | -10.54 US$ |
| 6 Meses | +15.67% | +10.27 US$ |
Analizando el Mercado con IA
Evaluando los últimos 30 días de historial y métricas fundamentales de WGS...
Estadísticas Clave
Cap. de Mercado
2.26B
Relación P/E
N/A
Rend. de Div.
N/A
Máx. 52 Semanas
$170.87
Mín. 52 Semanas
$32.21
Consenso de Analistas
CONSENSOCompra Fuerte
ALCISTA9100.0%
NEUTRAL00.0%
BAJISTA00.0%
Objetivos de Precios de Analistas a 52 Semanas
Objetivo Mín.
$74.00
$74.00
Objetivo Máx.
$103.00
$103.00
Actual$75.79
Objetivo Prom.$90.44
Recomendaciones de Analistas
Precio Objetivo:$90.44($74.00 - $103.00)
Pensamientos de la Comunidad
Comparta su análisis y sentimiento sobre WGS
Únase a la comunidad para compartir su análisis
Últimas Noticias para WGS
GeneDx Stock Is Down 30% In Last 1 Year, Can It Climb Again in 2027?
TIKR•24 sept 2026, 13:33



GeneDx and Beren Therapeutics Launch NPC GenomeComplete to Improve Diagnosis of Niemann-Pick Disease Type C
Business Wire•9 sept 2026, 12:30

3 Promising Genomics Stocks in the Spotlight in 2026
Zacks•8 sept 2026, 16:46

GeneDx CEO Katherine Stueland Recognized as a 2026 Fierce 50 Honoree
Business Wire•1 sept 2026, 10:55
Top Stock Picks for Week of August 24, 2026
Zacks•24 ago 2026, 19:07

GeneDx Announces Transformative Study Supporting Hospital-Wide Adoption of Rapid Genomic Sequencing at Seattle Children’s
Business Wire•24 ago 2026, 12:30

Can GENEDX HOLDINGS (WGS) Run Higher on Rising Earnings Estimates?
Zacks•19 ago 2026, 16:20